Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHardide Regulatory News (HDD)

Share Price Information for Hardide (HDD)

Share Price is delayed by 15 minutes
Get Live Data
73.00    -1.50 (-2.01%)
Bid:
72.00
Ask:
74.00
Spread: 2.00 (2.778%)
Market Cap: £57.53m
HDD Live PriceLast checked at - London Stock Exchange

Intraday Hardide Share Chart

AGM Trading Statement

18 Mar 2025 07:00

RNS Number : 9848A
Hardide PLC
18 March 2025
 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

 

 

18 March 2025

 

Hardide plc

("Hardide", the "Group" or the "Company")

 

AGM Trading Statement

 

Hardide plc (AIM: HDD), the provider of advanced surface coating technology, will be holding its Annual General Meeting at 11.30am today, at which the Chair will provide the following update on trading in the financial year ending 30 September 2025.

Year to date trading is in line with the Board's expectations.

We are pleased to report that we expect revenues for the first half year ending 31 March 2025 ("H1 FY25") to be approximately 30% ahead of the £2.1m reported in the equivalent prior year period ("H1 FY24"). Accordingly, we expect to report a positive EBITDA and a positive cash flow performance in H1 FY25 (H1 FY24: EBITDA loss of £0.5m, cash outflow of £0.7m, prior to proceeds from financing).

Revenue growth is being driven by the further development of our aerospace business, including initial revenues from the new contract announced in December 2024 to coat cargo door components for freight aircraft, together with some recovery in oil and gas sector demand compared with the previous H1.

The management team and the Board remain highly focused on pursuing initiatives to accelerate revenue growth and utilise spare production capacity, as set out in our 2024 annual report. This includes projects to:

· harmonise the production capabilities of our Martinsville factory in the USA with that of Bicester in the UK; and

· broaden the capability of our wet treatment line in the UK to enable this service to be offered directly to customers. Previously this facility has been used solely as a pre-treatment for CVD coatings.

The combined capital cost of these projects will be less than £0.1m, with completion expected in the third quarter of the financial year.

In view of encouraging trading to date, and the fresh approach to growing the business under new management, the Board believes that Hardide remains on track to deliver expectations for full year performance.

 

 

For further information:

Hardide plc

Matt Hamblin (CEO)

Simon Hallam (Finance Director)

Andrew Magson (Non-Executive Chair)

 

Tel: +44 (0) 1869 353 830

 

Cavendish Capital Markets Ltd - Nominated Adviser and Broker

Henrik Persson / Elysia Bough (Corporate Finance)

Jasper Berry / Dale Bellis (Sales)

 

Tel: +44 (0) 2072 200 500

 

Notes to editors:

www.hardide.com

 

Hardide develops, manufactures and applies advanced technology tungsten carbide/tungsten metal matrix coatings to a wide range of engineering components. Its patented technology is unique in combining in one material, a mix of toughness and resistance to abrasion, erosion and corrosion; together with the ability to coat accurately interior surfaces and complex geometries. The material is proven to offer dramatic improvements in component life, particularly when applied to components that operate in very aggressive environments. This results in cost savings through reduced downtime and increased operational efficiency as well as a reduced carbon footprint. Customers include leading companies operating in the energy sectors, valve and pump manufacturing, industrial gas turbine, precision engineering and aerospace industries.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTPKOBBQBKDFND
Date   Source Headline
5th Mar 20241:33 pmRNSHolding(s) in Company
5th Mar 202410:30 amRNSHolding(s) in Company
26th Feb 20242:04 pmRNSHolding(s) in Company
23rd Feb 202412:33 pmRNSHolding(s) in Company
21st Feb 20246:00 pmRNSResult of Fundraising
21st Feb 20244:35 pmRNSProposed equity fundraising
21st Feb 20244:30 pmRNSAudited Annual Report and Notice of AGM
8th Feb 20247:00 amRNSInterim CEO appointment
8th Feb 20247:00 amRNSPreliminary FY23 results & FY24 trading update
1st Nov 20237:00 amRNSBoard Changes
18th Oct 20237:00 amRNSYear End Trading Update
21st Jul 20239:02 amRNSHolding(s) in Company
26th May 20231:46 pmRNSDirector/PDMR Shareholding
17th May 20237:00 amRNSInterim Results
10th May 20237:00 amRNSHardide Coatings partners with Gardner Aerospace
23rd Mar 202312:18 pmRNSHolding(s) in Company
23rd Mar 202311:36 amRNSResult of AGM
23rd Mar 20237:00 amRNSAGM Statement
22nd Feb 20234:33 pmRNSPosting of Annual Report and Notice of AGM
8th Feb 20237:00 amRNSAnnual results for year ended 30 September 2022
25th Jan 20237:00 amRNSBoard Update
22nd Dec 20227:00 amRNSFunding and Annual Results Update
15th Nov 20228:16 amRNSHolding(s) in Company
27th Oct 20227:00 amRNSSupplier Approval & Order for Leonardo Helicopters
24th Oct 20223:00 pmRNSDirectorate Changes
13th Oct 20227:00 amRNSYear End Trading Update
9th Sep 202211:45 amRNSResult of Fundraising
9th Sep 20227:00 amRNSProposed equity fundraising
14th Jul 20227:00 amRNSTrading update
10th May 20227:00 amRNSResignation of Non-Executive Chairman
10th May 20227:00 amRNSInterim Results
5th Apr 20221:53 pmRNSHolding(s) in Company
22nd Mar 20228:37 amRNSHolding(s) in Company
11th Mar 202212:37 pmRNSResult of AGM
11th Mar 20227:00 amRNSAGM Statement
1st Mar 20227:00 amRNSContract Award
15th Feb 20224:15 pmRNSPosting of Annual Report and Notice of AGM
6th Dec 20217:00 amRNSPreliminary results
19th Oct 20217:00 amRNSHolding(s) in Company
7th Oct 20219:05 amRNSSecond Price Monitoring Extn
7th Oct 20219:00 amRNSPrice Monitoring Extension
7th Oct 20217:00 amRNSYear End Trading Update
9th Sep 20212:05 pmRNSSecond Price Monitoring Extn
9th Sep 20212:00 pmRNSPrice Monitoring Extension
9th Sep 20217:00 amRNSContract Award
14th Jul 20218:17 amRNSHolding(s) in Company
6th Jul 20217:00 amRNSNew Facility Receives Airbus Approval
5th Jul 20213:46 pmRNSHolding(s) in Company
7th Jun 202111:00 amRNSHolding(s) in Company
19th May 20215:37 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.